CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
3M™ Oral Rinse +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03421145
NCT03421145N/ACompleted
CompareCT.gov

A Prospective, Randomized, Blinded, Clinical Study to Evaluate Effects of an Oral Rinse on Plaque and Gingivitis

Solventum US LLC·interventional·Posted Feb 5, 2018·Updated Oct 1, 2024

In Brief

A clinical study evaluating 3M™ Oral Rinse, Vehicle Control Oral Rinse, and 2 other interventions for Plaque. Completed, enrolled 200 participants across 1 site.

Detailed Summary

Rinse contains an anti-plaque agent that helps prevent the accumulation of dental plaque associated with gingivitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque
CountriesUnited States
Collaborators3M

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 5, 2018
Enrollment StartDec 17, 2017
Primary CompletionJan 17, 2019
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 8.4 years ago

Interventions

3M™ Oral Rinsedevice

The Investigational Rinse contains a sugar-based surfactant using a proprietary formula. The intended use of the product is to help prevent and reduce plaque accumulation on the teeth and related gum-tissue inflammation (gingivitis).

Vehicle Control Oral Rinseother

The Placebo Comparator oral rinse is similar to the Experimental Oral Rinse only it does not contain the active ingredient.

PerioShield™ Oral Health Rinsedevice

PerioShield™ Oral Health Rinse (0.2% delmopinol hydrochloride) is marketed in the US and was purchased for use in this study.

Waterother

Purified bottled water containing no active ingredients.